Anna Goshua is an editorial intern at Spectrum. Previously, she interned at Medscape. She is a medical student at Stanford University and a journalism student in the Science, Health and Environmental Reporting Program at New York University.
Anna Goshua
Intern
Spectrum
From this contributor
Cluster of traits tied to rare mutations in autism-linked gene
Developmental delay, intellectual disability and behavioral issues are common among people who have mutations in MYT1L, a gene with strong ties to autism.
Cluster of traits tied to rare mutations in autism-linked gene
By
Anna Goshua
20 December 2021 | 3 min read
Pitfalls in using autism claims data: Q&A with Lindsay Shea
Insurance claims data are useful for autism research, but the field needs to standardize how they are mined, Shea says.
Pitfalls in using autism claims data: Q&A with Lindsay Shea
By
Anna Goshua
14 December 2021 | 6 min read
DNA methylation in autism, explained
How chemical tags called methyl groups position themselves on genetic sequences may hint at some of the causes of autism.
Myelin loss may explain how autism-linked DNA deletion affects cognition
Deleting a copy of the gene TBX1 depletes the fatty myelin insulation that surrounds neurons and reduces cognitive speed in mice.
Myelin loss may explain how autism-linked DNA deletion affects cognition
By
Anna Goshua
8 December 2021 | 3 min read
Dispatches from SfN 2021: Mitochondria, Rett therapy and oxytocin
These short reports from Spectrum journalists highlight some of the autism-related findings that caught our attention at the meeting this past week.
Dispatches from SfN 2021: Mitochondria, Rett therapy and oxytocin
By
Angie Voyles Askham, Laura Dattaro, Anna Goshua, Peter Hess
11 November 2021 | 9 min read
Explore more from The Transmitter
‘Tour de force’ study flags fount of interneurons in human brain
The newly discovered cell type might point to the origins of the inhibitory imbalance linked to autism and other conditions.
‘Tour de force’ study flags fount of interneurons in human brain
The newly discovered cell type might point to the origins of the inhibitory imbalance linked to autism and other conditions.
By
Holly Barker
29 January 2026 | 4 min read
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
By
Paul Middlebrooks
28 January 2026 | 1 min read
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
By
Angie Voyles Askham
27 January 2026 | 7 min read